Section: Surgical Oncology Curriculum: Curriculum, page 73
General
- Historically challenging
- Stimulates a strong graft rejection response
- Small intestine contains large amounts of lymphoid tissue
- Ischaemia and rejection increase intestinal permeability
- Allow translocation of bacteria from the lumen
- Operation often complex
- Stimulates a strong graft rejection response
- Graft rejection and infection remain major problems
- Results obtained are inferior to those obtained after other types of organ transplantation
Indications
- Indicated for intestinal failure requiring TPN
- Short gut, or intestinal dysfunction caused by:
- Intestinal atresia
- Necrotising enterocolitis
- Volvulus
- Disorders of motility
- Mesenteric infarction
- Crohn’s disease
- Trauma
- Desmoid tumours
- Short gut, or intestinal dysfunction caused by:
- Indications
- Recurrent line complications - sepsis or clots.
- TPN associated liver failure (SB transplantation is combined with liver transplantation)
- Frequent episodes of severe dehydration despite intravenous fluid administration in addition to parenteral nutrition
Technique
- May be carried out as an isolated procedure (highest survival)
- Performed together with a liver transplant
- Or as a component of a multivisceral transplant
- Deceased donor transplant
- Comprises the entire small bowel
- Not ascending colon
- SMA of the graft (with an aortic patch) is anastomosed to the recipient aorta
- SMV is anastomosed to the IVC or to the side of the Portal Vein
- Proximal end of SB graft anastomosed to the recipient jejunum or duodenum
- Distal end
- Anastomosed to right colon (with loop ileostomy)
- Or Direct end ileostomy
- Draining gastrostomy and feeding jejunostomy inserted
- Comprises the entire small bowel
- ½ of patients on long-term TPN also require liver transplant due to cholestatic liver disease
- Do both en-bloc
Implications of anastomosing SMV to IVC
- Liver metabolism and detoxification is being bypassed
- Results in increased ammonia
- Changes to protein and lipid metabolism.
- Increased risk of sepsis
- Increased immune activation
- Which can contribute to graft rejection.
Outcomes
- 1-year graft survival rate 65% 2009 - latest data suggests up 90% at 1 year
- For both isolate SB transplantation and for combined with liver
- 3 years, the graft survival rate is around 45%
- Survival better after isolated SB transplantation than after combined liver
- Loss of the graft usually equates with death
- Mortality due to sepsis and multi-organ failure
- Risk of infection heightened by the additional requirements for immunosuppression to control graft rejection
- Also accounts for the relatively high incidence of lymphoproliferative disease (10%)
- Because of the large amount of donor lymphoid tissue transplanted, GVHD may be an added complication
- Despite the hazards, small bowel transplantation offers pts with IF a chance to lead an active life, free from long-term nutritional support